Winston Crute, MD
Urology · Tuscaloosa, ALNPI 1922504331
Payments from drug & device makers
Across 205 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Boston Scientific$687
- AbbVie$413
- Sumitomo Pharma America, Inc.$400
- Medtronic$370
- Coloplast$252
- plus $2K from 28 others
What the payments were for
- Travel & lodging$1,14517%
- Food & beverage$5,65383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 31 | $2,367 |
| Boston Scientific | 15 | $687 |
| AbbVie | 23 | $413 |
| Sumitomo Pharma America, Inc. | 23 | $400 |
| Medtronic | 11 | $370 |
| Coloplast | 8 | $252 |
| Johnson & Johnson | 13 | $230 |
| Pfizer | 11 | $203 |
| Bayer | 7 | $139 |
| Endo Pharmaceuticals Inc. | 6 | $126 |
| Photocure Inc | 2 | $112 |
| KARL Storz Endoscopy-america | 1 | $106 |
| Intuitive Surgical | 1 | $105 |
| Olympus America Inc. | 4 | $104 |
| Procept Biorobotics Corporation | 3 | $100 |
| Immunitybio, Inc. | 4 | $91 |
| Endo USA, Inc. | 4 | $88 |
| Ferring Pharmaceuticals Inc. | 4 | $88 |
| Astellas Pharma US Inc | 4 | $82 |
| Halozyme Inc | 3 | $77 |
| Urogen Pharma, Inc. | 3 | $71 |
| Myriad Genetic Laboratories, Inc. | 3 | $67 |
| Antares Pharma, Inc. | 3 | $65 |
| Laborie Medical Technologies Corp. | 2 | $65 |
| Progenics Pharmaceuticals, Inc. | 3 | $63 |
| Smith+Nephew | 2 | $60 |
| ABC Home Medical Supply, Inc. | 2 | $59 |
| Blue Earth Diagnostics | 2 | $45 |
| Baxter Healthcare | 1 | $44 |
| Accord Healthcare, Inc. | 2 | $36 |
| Hollister Incorporated | 1 | $25 |
| AstraZeneca | 1 | $23 |
| Civco Medical Instruments | 1 | $20 |
| Provepharm Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,668
- Da Vinci Surgical System$105
- INTERSTIM$105
- Bulkamid$103
How this compares
$6,797 in reported general payments places this provider in the 60th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 19 | $266,890 |
| Lupron DepotLeuprolide Acetate | 20 | $217,778 |
| MyrbetriqMirabegron | 207 | $119,063 |
| GemtesaVibegron | 169 | $116,565 |
| Tamsulosin Hcl | 306 | $3,856 |
| Estradiol | 53 | $3,184 |
| Testosterone Cypionate | 50 | $1,172 |
| Dutasteride | 19 | $923 |
| Finasteride | 55 | $864 |
| Potassium Citrate ErPotassium Citrate | 13 | $641 |
| NitrofurantoinNitrofurantoin Macrocrystal | 32 | $526 |
| Cephalexin | 71 | $414 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 163 | $342 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 131 | $284 |
| Ciprofloxacin Hcl | 35 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $82 | $385,953226 claims |
| AbbVieLupron Depot | $413 | $217,77820 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $400 | $116,565169 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 179 urology providers in Alabama.
Other urology in Tuscaloosa
- Raymond PooreTuscaloosa$12K
- John DuffyTuscaloosa$8K
- James McMurrayHuntsville$4.7M
- Vincent BivinsHomewood$1.3M
- Charles WhiteMobile$735K
- Thomas ChiBirmingham$628K
- Charles BuggHomewood$544K
- Charles PeytonBirmingham$543K
- Brian ChristineHomewood$372K
- Austin LutzHomewood$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.